The Journal of Industry and Technology

Industrial Analytical Instrumentation

Euro Technology

Serving industry for over 36 years
Three leading magazines for key executives,  engineers, universities,
manufacturers, laboratory technicians, scientists, and research establishments

Life sciences and clinical instrumentation

BIOTRONIK's Itrevia 7 HF-T is First CRT-D

All Previously Implanted Itrevia 7 HF-T Devices Now Also Approved for MRI Scans of the Cardiac Area.

BIOTRONIK, the world's leader in MR conditional cardiac devices, has announced that its Itrevia 7 HF-T cardiac resynchronization therapy defibrillator (CRT-D) has now been approved for full-body MRI scanning in Japan.

The device was launched in Japan in July of last year, and all already implanted devices have been deemed safe for full-body MRI scans at 1.5 tesla strength. Meaning, physicians can take MRI images of the heart area of these device patients--an unprecedented aid when treating this patient group. This is the first and only CRT-D in Japan with such conditions.

Dr. Seiji Takatsuki, Associate Professor of Cardiovascular Medicine at Keio University Hospital, said the announcement marks a huge leap in treating CRT-D patients with comorbidities. "In addition to having indispensable diagnostic information in the field of cerebrovascular treatment and orthopedics, MRI offers extensive diagnostic cardiovascular information. Many CRT-D patients undergo a cardiac MRI (CMR) before implantation to assess the late gadolinium enhancement. However, until now CMR after CRT-D implantation was not possible, thus no assessment on the presence or absence of any changes could be achieved. Now with the condition change, post-operative cardiac MRI examination has become feasible with the Itrevia 7 HF-T series."

MRI offers very detailed images, so it is the method of choice for the diagnosis of many injuries and body conditions. Until recently, patients with cardiac devices were denied any MRI access due to the potential hazard the strong magnetic fields and radio waves would have on cardiac devices and leads. However, many of these patients will need an MRI scan within their lifetime.[1]

Addressing this issue through design and scrupulous testing, BIOTRONIK developed its ProMRI technology and now boasts the world's largest portfolio of MR conditional devices and leads. Japan is the world's largest MRI market with more MRI scanners per capita than any other country: approximately 47 registered machines per one million people[2]. Itrevia 7 will allow more patients access to this superior diagnostic tool, even in the cardiac area.

"We're determined to help our patients live normal lives," commented Jeffrey Annis, Managing Director BIOTRONIK Japan. "Having access to MRI scanning is part of that. Physicians have long asked for MRI access in the cardiac area of device patients and we are answering that call."

References
[1] Kalin R and Stanton MS, Pacing Clin Electrophysiol. 2005, 28 (4).

[2]
OECD Health Statistics 2013 http://dx.doi.org/10.1787/888932917275.

For further information, view website: www.biotronik.com or e-mail: manuela.schildwaechter@biotronik.com 
Refer to page 995

Quick page links - Display rates - Features - Magazine profile - Home page - Company index - Page 982


Industrial and Technological Publications
Leading the way in on-line magazine publishing
The Journal of Industry and Technology - Euro Technology - Industrial Analytical Instrumentation
Title registered in London 1978. Registration number 2334966

Twitter: www.twitter.com/@thejournalofind - Twitter: www.twitter.com/@eurotechnologym - Twitter: www,twitter.com/@industrialanaly
Google+: www.google.com/+ThejournalofindustryandtechnologyBiz21 Linkedin: www.linkedin.com/in/williamdigbyhammertonthejourna
Google+: www.Google.com/+Eurotechnologymagazine21E  Google+: www.google.com /+Industrialanalyticalinstrumentation21IA
Follow on Facebook: http://facebook.com/pages/The-Journal-of-Industry-and-Technology/171016159602089